Case Reports in Clinical Medicine
Vol.3 No.10(2014), Paper ID 50793, 6
pages
DOI:10.4236/crcm.2014.310122
Compassionate Use of Midostaurin in Myeloid and Lymphoid Neoplasia with FGFR1 Abnormality
Photis Beris, Monika Nagy, Daniel Robert, Kaveh Samii, Tom McKee, Jovita Schuler
Department of Haematology, Unilabs Coppet, Coppet, Switzerland
Division of Haematology, University Hospital of Geneva, Geneva, Switzerland
Division of Haematology, University Hospital of Geneva, Geneva, Switzerland
Division of Haematology, University Hospital of Geneva, Geneva, Switzerland
Department of Pathology, CMU, Geneva, Switzerland
Novartis Pharma Switzerland, Rotkreuz, Switzerland
Copyright © 2014 Photis Beris, Monika Nagy, Daniel Robert, Kaveh Samii, Tom McKee, Jovita Schuler et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Beris, P. , Nagy, M. , Robert, D. , Samii, K. , McKee, T. and Schuler, J. (2014) Compassionate Use of Midostaurin in Myeloid and Lymphoid Neoplasia with FGFR1 Abnormality.
Case Reports in Clinical Medicine,
3, 560-565. doi:
10.4236/crcm.2014.310122.